You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Professional Issues Articles
Popular Professional Issues Articles
Highly Recommended Professional Issues Articles
Send a link to this page to your friends and colleagues.
Scientists at Northwestern University in Evanston, Illinois, have developed a synthetic version of high-density lipoprotein (HDL), the "good" cholesterol that doctors are always nudging their patients with diabetes to monitor.
HDL is sometimes described as a "sponge" because of its ability to "bind" cholesterol and keep it from leading to heart-threatening plaque formation on arterial walls.
The synthetic HDL, which completely mimics natural HDL in both structure and effect, uses a gold "nanoparticle" (an object that is 100 or fewer billionths of a meter in size) as its core. Gold is both non-toxic and easily shaped, making it an ideal substrate for the synthetic. To create the synthetic HDL, two lipids and a protein called APOA1 are layered on the gold base, creating a nanoparticle 18 billionths of a meter in size.
One problem that the synthetic might solve is how to increase HDL in people's bodies. Although there are drugs that decrease levels of "bad" low-density lipoprotein (LDL) in the bloodstream, nobody is quite sure how increase the levels of HDL. Synthetic HDL could potentially be the basis of a drug therapy that allows "good" cholesterol to be regulated at will.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.